These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 9724022

  • 1. Differential responses of estrogen target tissues in rats including bone to clomiphene, enclomiphene, and zuclomiphene.
    Turner RT, Evans GL, Sluka JP, Adrian MD, Bryant HU, Turner CH, Sato M.
    Endocrinology; 1998 Sep; 139(9):3712-20. PubMed ID: 9724022
    [Abstract] [Full Text] [Related]

  • 2. Clomiphene prevents cancellous bone loss from tibia of ovariectomized rats.
    Jimenez MA, Magee DE, Bryant HU, Turner RT.
    Endocrinology; 1997 May; 138(5):1794-800. PubMed ID: 9112370
    [Abstract] [Full Text] [Related]

  • 3. Raloxifene inhibits bone turnover and prevents further cancellous bone loss in adult ovariectomized rats with established osteopenia.
    Evans GL, Bryant HU, Magee DE, Turner RT.
    Endocrinology; 1996 Oct; 137(10):4139-44. PubMed ID: 8828469
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of enclomiphene and zuclomiphene in men with hypogonadism on long-term clomiphene citrate treatment.
    Helo S, Mahon J, Ellen J, Wiehle R, Fontenot G, Hsu K, Feustel P, Welliver C, McCullough A.
    BJU Int; 2017 Jan; 119(1):171-176. PubMed ID: 27511863
    [Abstract] [Full Text] [Related]

  • 5. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
    Ke HZ, Simmons HA, Pirie CM, Crawford DT, Thompson DD.
    Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
    [Abstract] [Full Text] [Related]

  • 6. The effects of raloxifene on tibia histomorphometry in ovariectomized rats.
    Evans G, Bryant HU, Magee D, Sato M, Turner RT.
    Endocrinology; 1994 May; 134(5):2283-8. PubMed ID: 8156931
    [Abstract] [Full Text] [Related]

  • 7. Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats.
    Ke HZ, Chen HK, Qi H, Pirie CM, Simmons HA, Ma YF, Jee WS, Thompson DD.
    Bone; 1995 Nov; 17(5):491-6. PubMed ID: 8579962
    [Abstract] [Full Text] [Related]

  • 8. Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats.
    Qu Q, Zheng H, Dahllund J, Laine A, Cockcroft N, Peng Z, Koskinen M, Hemminki K, Kangas L, Väänänen K, Härkönen P.
    Endocrinology; 2000 Feb; 141(2):809-20. PubMed ID: 10650964
    [Abstract] [Full Text] [Related]

  • 9. The estrogenic effects of clomiphene during the neonatal period in the rat.
    Clark JH, Guthrie SC.
    J Steroid Biochem; 1983 May; 18(5):513-7. PubMed ID: 6406767
    [Abstract] [Full Text] [Related]

  • 10. Idoxifene: a novel selective estrogen receptor modulator prevents bone loss and lowers cholesterol levels in ovariectomized rats and decreases uterine weight in intact rats.
    Nuttall ME, Bradbeer JN, Stroup GB, Nadeau DP, Hoffman SJ, Zhao H, Rehm S, Gowen M.
    Endocrinology; 1998 Dec; 139(12):5224-34. PubMed ID: 9832463
    [Abstract] [Full Text] [Related]

  • 11. Evidence that ibuprofen antagonizes selective actions of estrogen and tamoxifen on rat bone.
    Sibonga JD, Bell NH, Turner RT.
    J Bone Miner Res; 1998 May; 13(5):863-70. PubMed ID: 9610751
    [Abstract] [Full Text] [Related]

  • 12. Specific bone-protective effects of metabolites/derivatives of tamoxifen and clomiphene in ovariectomized rats.
    Ruenitz PC, Shen Y, Li M, Liang H, Whitehead RD, Pun S, Wronski TJ.
    Bone; 1998 Dec; 23(6):537-42. PubMed ID: 9855462
    [Abstract] [Full Text] [Related]

  • 13. Dose-response effects of 2-methoxyestradiol on estrogen target tissues in the ovariectomized rat.
    Sibonga JD, Lotinun S, Evans GL, Pribluda VS, Green SJ, Turner RT.
    Endocrinology; 2003 Mar; 144(3):785-92. PubMed ID: 12586754
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of isomers of clomiphene citrate on reproductive tissues in male mice.
    Fontenot GK, Wiehle RD, Podolski JS.
    BJU Int; 2016 Feb; 117(2):344-50. PubMed ID: 26220499
    [Abstract] [Full Text] [Related]

  • 15. Geometric isomers of substituted triphenylethylenes and antiestrogen action.
    Jordan VC, Haldemann B, Allen KE.
    Endocrinology; 1981 Apr; 108(4):1353-61. PubMed ID: 6781873
    [Abstract] [Full Text] [Related]

  • 16. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
    Iwaniec UT, Mosekilde L, Mitova-Caneva NG, Thomsen JS, Wronski TJ.
    Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
    [Abstract] [Full Text] [Related]

  • 17. Mechanism of action of estrogen on cancellous bone balance in tibiae of ovariectomized growing rats: inhibition of indices of formation and resorption.
    Turner RT, Evans GL, Wakley GK.
    J Bone Miner Res; 1993 Mar; 8(3):359-66. PubMed ID: 8456590
    [Abstract] [Full Text] [Related]

  • 18. Effects of CP-336,156, a new, nonsteroidal estrogen agonist/antagonist, on bone, serum cholesterol, uterus and body composition in rat models.
    Ke HZ, Paralkar VM, Grasser WA, Crawford DT, Qi H, Simmons HA, Pirie CM, Chidsey-Frink KL, Owen TA, Smock SL, Chen HK, Jee WS, Cameron KO, Rosati RL, Brown TA, Dasilva-Jardine P, Thompson DD.
    Endocrinology; 1998 Apr; 139(4):2068-76. PubMed ID: 9528995
    [Abstract] [Full Text] [Related]

  • 19. Advantages of raloxifene over alendronate or estrogen on nonreproductive and reproductive tissues in the long-term dosing of ovariectomized rats.
    Sato M, Bryant HU, Iversen P, Helterbrand J, Smietana F, Bemis K, Higgs R, Turner CH, Owan I, Takano Y, Burr DB.
    J Pharmacol Exp Ther; 1996 Oct; 279(1):298-305. PubMed ID: 8859007
    [Abstract] [Full Text] [Related]

  • 20. Ovarian status influences the skeletal effects of tamoxifen in adult rats.
    Sibonga JD, Evans GL, Hauck ER, Bell NH, Turner RT.
    Breast Cancer Res Treat; 1996 Oct; 41(1):71-9. PubMed ID: 8932878
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.